| An overview of the pharmacological properties and potential applications of natural monoterpenes A Koziol, A Stryjewska, T Librowski, K Salat, M Gawel, A Moniczewski, ... Mini reviews in medicinal chemistry 14 (14), 1156-1168, 2014 | 199 | 2014 |
| The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity U Kosak, B Brus, D Knez, S Zakelj, J Trontelj, A Pislar, R Sink, M Jukic, ... Journal of medicinal chemistry 61 (1), 119-139, 2018 | 137 | 2018 |
| Development of an in-vivo active reversible butyrylcholinesterase inhibitor U Košak, B Brus, D Knez, R Šink, S Žakelj, J Trontelj, A Pišlar, J Šlenc, ... Scientific reports 6 (1), 39495, 2016 | 134 | 2016 |
| Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice K Sałat, B Filipek Journal of Zhejiang University. Science. B 16 (3), 167, 2015 | 93 | 2015 |
| Chemotherapy-induced peripheral neuropathy: part 1—current state of knowledge and perspectives for pharmacotherapy K Sałat Pharmacological reports 72, 486-507, 2020 | 90 | 2020 |
| Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity K Sałat Pharmacological Reports 72, 508-527, 2020 | 82 | 2020 |
| Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor K Sałat, A Siwek, G Starowicz, T Librowski, G Nowak, U Drabik, ... Neuropharmacology 99, 301-307, 2015 | 76 | 2015 |
| Transient receptor potential channels-emerging novel drug targets for the treatment of pain K Salat, A Moniczewski, T Librowski Current medicinal chemistry 20 (11), 1409-1436, 2013 | 75 | 2013 |
| Antiallodynic and antihyperalgesic activity of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one compared to pregabalin in chemotherapy-induced neuropathic … K Sałat, A Cios, E Wyska, R Sałat, S Mogilski, B Filipek, K Więckowski, ... Pharmacology Biochemistry and Behavior 122, 173-181, 2014 | 64 | 2014 |
| Nitrogen, oxygen or sulfur containing heterocyclic compounds as analgesic drugs used as modulators of the nitroxidative stress K Salat, A Moniczewski, T Librowski Mini reviews in medicinal chemistry 13 (3), 335-352, 2013 | 61 | 2013 |
| Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo A Więckowska, K Więckowski, M Bajda, B Brus, K Sałat, P Czerwińska, ... Bioorganic & medicinal chemistry 23 (10), 2445-2457, 2015 | 60 | 2015 |
| Lipopolysaccharide-induced model of neuroinflammation: mechanisms of action, research application and future directions for its use A Skrzypczak-Wiercioch, K Sałat Molecules 27 (17), 5481, 2022 | 57 | 2022 |
| Anticonvulsant active inhibitor of GABA transporter subtype 1, tiagabine, with activity in mouse models of anxiety, pain and depression K Sałat, A Podkowa, P Kowalczyk, K Kulig, A Dziubina, B Filipek, ... Pharmacological Reports 67 (3), 465-472, 2015 | 57 | 2015 |
| New investigational drugs for the treatment of neuropathic pain K Sałat, P Kowalczyk, B Gryzło, A Jakubowska, K Kulig Expert opinion on investigational drugs 23 (8), 1093-1104, 2014 | 53 | 2014 |
| GABA transporters as targets for new drugs K Sałat, K Kulig Future medicinal chemistry 3 (2), 211-222, 2011 | 52 | 2011 |
| Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT1A receptor selective agonist, NLX-112 in mouse models of pain K Sałat, M Kołaczkowski, A Furgała, A Rojek, J Śniecikowska, MA Varney, ... Neuropharmacology 125, 181-188, 2017 | 42 | 2017 |
| Novel, highly potent and in vivo active inhibitor of GABA transporter subtype 1 with anticonvulsant, anxiolytic, antidepressant and antinociceptive properties K Sałat, A Podkowa, N Malikowska, F Kern, J Pabel, E Wojcieszak, ... Neuropharmacology 113, 331-342, 2017 | 40 | 2017 |
| The effect of GABA transporter 1 (GAT1) inhibitor, tiagabine, on scopolamine-induced memory impairments in mice K Sałat, A Podkowa, S Mogilski, P Zaręba, K Kulig, R Sałat, N Malikowska, ... Pharmacological Reports 67, 1155-1162, 2015 | 40 | 2015 |
| Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one in mice K Sałat, K Gawlik, J Witalis, D Pawlica-Gosiewska, B Filipek, B Solnica, ... Naunyn-schmiedeberg's Archives of Pharmacology 386, 493-505, 2013 | 39 | 2013 |
| Analgesic, anticonvulsant and antioxidant activities of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one dihydrochloride in mice K Salat, A Moniczewski, R Salat, M Janaszek, B Filipek, B Malawska, ... Pharmacology Biochemistry and Behavior 101 (1), 138-147, 2012 | 38 | 2012 |
